These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7571653)

  • 21. Motor performance as a function of verbal, nonverbal interference and handedness.
    Kumar S; Mandal MK
    Int J Neurosci; 2004 Jul; 114(7):787-94. PubMed ID: 15204044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
    Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
    Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological trauma and family functioning: toward a social neuropsychology.
    Howe GW
    Psychiatry; 1994 Aug; 57(3):275-7. PubMed ID: 7800775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.
    Pessiglione M; Czernecki V; Pillon B; Dubois B; Schüpbach M; Agid Y; Tremblay L
    J Cogn Neurosci; 2005 Dec; 17(12):1886-96. PubMed ID: 16356326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.
    Scholtissen B; Verhey FR; Adam JJ; Weber W; Leentjens AF
    Clin Neuropharmacol; 2006; 29(5):276-85. PubMed ID: 16960473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection of L-dopa response in parkinsonian patients with a standardized tracking test.
    Albani C; Buck A
    Adv Neurol; 1993; 60():386-9. PubMed ID: 8420158
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Parkinson's disease.
    Langston JW
    Neurology; 1990 Oct; 40(10 Suppl 3):suppl 70-4; discussion 75-6. PubMed ID: 2215975
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contribution and limitations of evaluation scales in Parkinson's disease].
    Tison F
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():76-80. PubMed ID: 10916040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper extremity motor measures of Tap Test response in Normal Pressure Hydrocephalus.
    Tsakanikas D; Katzen H; Ravdin LD; Relkin NR
    Clin Neurol Neurosurg; 2009 Nov; 111(9):752-7. PubMed ID: 19720451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. It's not just about the score: using the full clinical picture to identify future fallers.
    Dibble LE
    J Neurol Phys Ther; 2008 Sep; 32(3):148-9. PubMed ID: 18978672
    [No Abstract]   [Full Text] [Related]  

  • 35. Visuomotor priming effects in Parkinson's disease patients depend on the match between the observed and the executed action.
    Castiello U; Ansuini C; Bulgheroni M; Scaravilli T; Nicoletti R
    Neuropsychologia; 2009 Feb; 47(3):835-42. PubMed ID: 19138692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of stimulation in the ventral intermediate nucleus of the thalamus on limb control in Parkinson's disease: a case study.
    Pfann KD; Penn RD; Shannon KM; Shapiro MB; Corcos DM
    Mov Disord; 1996 May; 11(3):311-6. PubMed ID: 8723149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor performance in parkinsonism following stereotactic thalamotomy.
    Struppler A; Gurfinkel V; Mathis J; Max T
    Adv Neurol; 1993; 60():403-7. PubMed ID: 8420162
    [No Abstract]   [Full Text] [Related]  

  • 38. Driving ability in Parkinson's disease: current status of research.
    Klimkeit EI; Bradshaw JL; Charlton J; Stolwyk R; Georgiou-Karistianis N
    Neurosci Biobehav Rev; 2009 Mar; 33(3):223-31. PubMed ID: 18775450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
    J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of verbal working memory in patients with Parkinson's disease.
    Gilbert B; Belleville S; Bherer L; Chouinard S
    Neuropsychology; 2005 Jan; 19(1):106-14. PubMed ID: 15656768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.